MedPath

Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers

Not Applicable
Conditions
colorectal cancers
Registration Number
JPRN-UMIN000000961
Lead Sponsor
Dept. Surgey Kyoto University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

Excluded are cases with conditions as below: 1) Peritoneal or pleural fluid retention to be drainaged. 2) Multiple malignancies to be treated. 3) Peripheral neural disturbances. 4) Active infectious diseases. 5) Severe watery diarrhea. 6) Mental disturbances. 7) Treatment history of continuous, oral or intravenous steroid therapy. 8) Previous history of ischemic heart diseases. 9) Coexistent severe diseases including pulmonary fibrosis, interstitial pneumonia, ileus, uncontrollable diabetes, cardiac dysfunction, hepatic failure, or renal failure. 10) Pregnant. 11) Previous history of severe drug-induced allergy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Curative resection rates of liver metastases
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath